Propolis polyphenol nanosheet for synergistic cancer chemo-photothermal therapy

Abstract

Two-dimensional (2D) carbon-based nanostructures hold great promise as near-infrared (NIR) photothermal materials, yet their widespread use has been hindered by labor-intensive and costly fabrication processes. Here, a novel, cost-effective approach is presented to produce photothermal materials derived from the polyphenolic fraction of propolis (PFP) for the first time. The method involves the pyrolysis of PFP under a neutral atmosphere, resulting in the formation of 2D PFP-based nanosheets (PFPNS) measuring 50–100 nm in size with efficient photothermal properties. Then, a layer-by-layer nanohybrid structure comprising PFPNS, polydopamine (PDA), mesoporous silica (MS), and polyethyleneimine (PEI) layers (PFPNS@PDA@MS-PEI) was designed as a versatile platform for drug delivery. Specifically, the anticancer drug doxorubicin (DOX) was loaded onto the nanohybrid (PFPNS@PDA@MS(DOX)-PEI) for targeted delivery to cancerous cells. Each layer of the nanohybrid serves a distinct purpose, enhancing functionality and efficacy. The NIR-responsive PFPNS@PDA component facilitates accelerated drug release and induces hyperthermic effects on cancer cells upon NIR irradiation. The MS structure enables high drug loading capacity (approximately 83.3%), while the pH-responsive PEI layer promotes cellular uptake and facilitates drug release within the acidic microenvironment of cancer cells. Combining NIR irradiation with chemotherapy results in a synergistic effect, leading to the eradication of 67% of MCF-7 breast cancer cells. The demonstrated efficacy, coupled with the non-toxic nature of the nanohybrid, positions it as a promising candidate for synergistic chemo-photothermal therapy of tumor tissues.